Breathe Easier, Live Better: How RAVCARE COPD Can Empower You

Chronic obstructive pulmonary disease (COPD) is a serious lung condition affecting millions worldwide. While millions struggle with it, a staggering 70% remain undiagnosed. This makes early intervention and proper management crucial.

The Challenge: Getting Diagnosed and Staying on Top of COPD

Traditionally, diagnosing COPD relies on pulmonary function tests (PFTs). These tests are important, but scheduling them can be inconvenient. Even then, interpreting PFT results can be complex.

RAVCARE’s Secret Weapon: AI for Accurate Diagnosis and Beyond

RAVCARE COPD Digital Therapeutics steps in with a revolutionary approach. Our AI software analyzes PFT results with unmatched accuracy, exceeding even the combined expertise of multiple pulmonologists. This means faster, more reliable diagnoses, putting you on the path to better management sooner.

Revolutionizing Health by Reclaiming Cardiometabolic Well-being.

Empowering people to take control of their chronic conditions through personalized digital therapeutics.

Vivify Health has created the world’s first remote care platform based upon consumer mobile devices and is among the fastest growing digital health companies. The Vivify cloud platform has been highly scaled, connecting biometric and mobile devices with electronic health records, for some of the largest health systems in the U.S. Vivify's intuitive user experience enables patients of any age to easily maintain their own health at home while remaining constantly connected with their providers, family and friends.

Vivify Health customers are hospital systems, health plans, insurers, home health, accountable care organizations and large employers, on a path towards direct-to-consumer. Vivify is very well funded, guided by experienced healthcare IT innovators and has been selected as a partner by the largest global companies in consumer electronics, telecommunications and healthcare information technology.